157 related articles for article (PubMed ID: 19580433)
1. Influenza genome analysis using pyrosequencing method: current applications for a moving target.
Deyde VM; Gubareva LV
Expert Rev Mol Diagn; 2009 Jul; 9(5):493-509. PubMed ID: 19580433
[TBL] [Abstract][Full Text] [Related]
2. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
Duwe S; Schweiger B
J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
[TBL] [Abstract][Full Text] [Related]
3. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
Lackenby A; Democratis J; Siqueira MM; Zambon MC
Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
5. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
[TBL] [Abstract][Full Text] [Related]
6. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.
Ciblak MA; Hasoksuz M; Escuret V; Valette M; Gul F; Yilmaz H; Turan N; Bozkaya E; Badur S
J Med Virol; 2009 Sep; 81(9):1645-51. PubMed ID: 19626608
[TBL] [Abstract][Full Text] [Related]
8. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
Deyde VM; Okomo-Adhiambo M; Sheu TG; Wallis TR; Fry A; Dharan N; Klimov AI; Gubareva LV
Antiviral Res; 2009 Jan; 81(1):16-24. PubMed ID: 18835410
[TBL] [Abstract][Full Text] [Related]
9. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus resistance to oseltamivir: what are the implications?
Fleming DM; Elliot AJ; Meijer A; Paget WJ
Eur J Public Health; 2009 Jun; 19(3):238-9. PubMed ID: 19221019
[No Abstract] [Full Text] [Related]
12. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season.
Kawakami C; Obuchi M; Saikusa M; Noguchi Y; Ujike M; Odagiri T; Iwata M; Toyozawa T; Tashiro M
Jpn J Infect Dis; 2009 Jan; 62(1):83-6. PubMed ID: 19168972
[No Abstract] [Full Text] [Related]
13. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
14. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.
Higgins RR; Eshaghi A; Burton L; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jan; 44(1):91-3. PubMed ID: 19019729
[TBL] [Abstract][Full Text] [Related]
15. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
[TBL] [Abstract][Full Text] [Related]
16. Pyrosequencing: nucleotide sequencing technology with bacterial genotyping applications.
Clarke SC
Expert Rev Mol Diagn; 2005 Nov; 5(6):947-53. PubMed ID: 16255635
[TBL] [Abstract][Full Text] [Related]
17. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
[TBL] [Abstract][Full Text] [Related]
18. Implications of antiviral resistance of influenza viruses.
Monto AS
Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
[No Abstract] [Full Text] [Related]
19. Assembly and characterization of pandemic influenza A H1N1 genome in nasopharyngeal swabs using high-throughput pyrosequencing.
Bartolini B; Chillemi G; Abbate I; Bruselles A; Rozera G; Castrignanò T; Paoletti D; Picardi E; Desideri A; Pesole G; Capobianchi MR
New Microbiol; 2011 Oct; 34(4):391-7. PubMed ID: 22143812
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
Enserink M
Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
